Deutsche Märkte geschlossen

Myomo, Inc. (MYO)

NYSE American - NYSE American Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
3,8300-0,2300 (-5,67%)
Börsenschluss: 04:00PM EDT
3,8800 +0,05 (+1,31%)
Nachbörse: 04:34PM EDT

Myomo, Inc.

137 Portland Street
4th Floor
Boston, MA 02114
United States
617-996-9058
https://myomo.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter101

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Paul R. GudonisChairman, President & CEO526,56kN/A1955
Mr. David A. HenryChief Financial Officer401,56kN/A1961
Dr. Harry Kovelman M.D.Chief Medical Officer426,03kN/A1959
Colin AndersonGlobal Director of OperationsN/AN/AN/A
Mr. Joseph ChicoskieDirector of MarketingN/AN/AN/A
Ms. Galina ShtivelmanSenior Director of Human ResourcesN/AN/AN/A
Mr. Micah J. MitchellChief Commercial Officer317,39kN/A1976
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Corporate Governance

Myomo, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.